These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7479175

  • 1. The subcutaneous array: a new lead adjunct for the transvenous ICD to lower defibrillation thresholds.
    Higgins SL, Alexander DC, Kuypers CJ, Brewster SA.
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1540-8. PubMed ID: 7479175
    [Abstract] [Full Text] [Related]

  • 2. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group.
    Baker JH, Epstein AE, Voshage-Stahl L.
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974
    [Abstract] [Full Text] [Related]

  • 3. Fully transvenous cardioverter defibrillators: rare need for subcutaneous patch with two newer-generation systems.
    Manolis AS, Rastegar H, Wang PJ, Estes NA.
    Am Heart J; 1994 Oct; 128(4):808-15. PubMed ID: 7942452
    [Abstract] [Full Text] [Related]

  • 4. Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation.
    Verma A, Kaplan AJ, Sarak B, Oosthuizen R, Beardsall M, Higgenbottam J, Wulffhart Z, Khaykin Y.
    J Interv Card Electrophysiol; 2010 Nov; 29(2):127-33. PubMed ID: 20865309
    [Abstract] [Full Text] [Related]

  • 5. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
    Rashba EJ, Farasat M, Kirk MM, Shorofsky SR, Peters RW, Gold MR.
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of shock waveforms and lead configurations for defibrillation.
    Jung W, Manz M, Moosdorf R, Spehl S, Wolpert C, Korte T, Lüderitz B.
    Am Heart J; 1994 Apr; 127(4 Pt 2):985-93. PubMed ID: 8160603
    [Abstract] [Full Text] [Related]

  • 7. Optimal method to achieve consistently low defibrillation energy requirements.
    Winter J, Zimmermann N, Lidolt H, Dees H, Perings C, Vester EG, Poll L, Schipke JD, Contzen K, Gams E.
    Am J Cardiol; 2000 Nov 02; 86(9A):71K-75K. PubMed ID: 11084103
    [Abstract] [Full Text] [Related]

  • 8. Implantable transvenous cardioverter-defibrillators.
    Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D.
    Circulation; 1993 Apr 02; 87(4):1152-68. PubMed ID: 8462144
    [Abstract] [Full Text] [Related]

  • 9. Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling Study.
    Heist EK, Belalcazar A, Stahl W, Brouwer TF, Knops RE.
    JACC Clin Electrophysiol; 2017 Apr 02; 3(4):405-414. PubMed ID: 29759454
    [Abstract] [Full Text] [Related]

  • 10. Influence of anodal electrode position on transvenous defibrillation efficacy in humans: a prospective randomized comparison.
    Markewitz A, Kaulbach H, Mattke S, Müller D, Bernutz C, Hoffmann E, Weinhold C, Steinbeck G, Reichart B.
    Pacing Clin Electrophysiol; 1997 Sep 02; 20(9 Pt 1):2193-9. PubMed ID: 9309743
    [Abstract] [Full Text] [Related]

  • 11. Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: comparison with a standard monophasic device using the same lead system.
    Natale A, Sra J, Axtell K, Maglio C, Dhala A, Deshpande S, Jazayeri M, Wase A, Akhtar M.
    J Am Coll Cardiol; 1994 Aug 02; 24(2):406-12. PubMed ID: 8034875
    [Abstract] [Full Text] [Related]

  • 12. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II.
    Gradaus R, Block M, Seidl K, Brunn J, Isgro F, Hammel D, Hauer B, Breithardt G, Bocker D.
    J Cardiovasc Electrophysiol; 2001 Aug 02; 12(8):921-7. PubMed ID: 11513444
    [Abstract] [Full Text] [Related]

  • 13. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads.
    Kettering K, Mewis C, Dörnberger V, Vonthein R, Bosch RF, Seipel L, Kühlkamp V.
    Pacing Clin Electrophysiol; 2004 Oct 02; 27(10):1355-61. PubMed ID: 15511244
    [Abstract] [Full Text] [Related]

  • 14. Prospective randomized comparison of 65%/65% versus 42%/42% tilt biphasic waveform on defibrillation thresholds in humans.
    Shepard RK, DeGroot PJ, Pacifico A, Wood MA, Ellenbogen KA.
    J Interv Card Electrophysiol; 2003 Jun 02; 8(3):221-5. PubMed ID: 12815309
    [Abstract] [Full Text] [Related]

  • 15. Italian multicenter clinical experience with endocardial defibrillation: acute and long-term results in 307 patients. The Italian Endotak Investigator Group.
    Raviele A, Gasparini G.
    Pacing Clin Electrophysiol; 1995 Mar 02; 18(3 Pt 2):599-608. PubMed ID: 7777424
    [Abstract] [Full Text] [Related]

  • 16. Safety, feasibility and long term follow-up of a non-thoracotomy defibrillation system in patients with inducible sustained ventricular tachycardia/fibrillation.
    Gielchinsky I, Rothbart ST, Parsonnet V, Hussain SM, Fuzesi L, Fontana CA, Checchio T, Neglia D.
    J Cardiovasc Surg (Torino); 1994 Dec 02; 35(6 Suppl 1):111-3. PubMed ID: 7775521
    [Abstract] [Full Text] [Related]

  • 17. Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.
    Fotuhi PC, Ideker RE, Idriss SF, Callihan RL, Walker RG, Alt EU.
    Circulation; 1995 Nov 15; 92(10):3082-8. PubMed ID: 7586279
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with downsized lower energy output implantable cardioverter defibrillators. Ventak Mini II Clinical Investigators.
    Boriani G, Frabetti L, Biffi M, Sallusti L.
    Int J Cardiol; 1998 Oct 30; 66(3):261-6. PubMed ID: 9874078
    [Abstract] [Full Text] [Related]

  • 19. [Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].
    Himmrich E, Liebrich A, Michel U, Neuzner J, Pitschner H, Heisel A, Vester E, Ganschov U, Jung J.
    Z Kardiol; 1999 Feb 30; 88(2):103-12. PubMed ID: 10209831
    [Abstract] [Full Text] [Related]

  • 20. Initial experience with a new transvenous defibrillation system.
    Trappe HJ, Klein H, Fieguth HG, Kielblock B, Wenzlaff P, Lichtlen PR.
    Pacing Clin Electrophysiol; 1993 Jan 30; 16(1 Pt 2):134-40. PubMed ID: 7681560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.